• Distinct Senescence Responses to Enzalutamide and DNA Damage

  2026-08-05

  This study dissects how enzalutamide (MDV3100) and DNA damage inducers elicit fundamentally different senescence phenotypes in prostate cancer cells. The findings clarify why only DNA damage-induced senescence promotes sensitivity to Bcl-xL senolytics, informing context-specific therapeutic strategies.

• ω-Agatoxin IVA TFA: Precision Tools for Synaptic Transmissio

  2026-08-05

  ω-Agatoxin IVA TFA empowers researchers with unmatched specificity for dissecting P/Q-type calcium channel function in neurophysiology and epilepsy models. This article details optimized workflows, protocol enhancements, and troubleshooting strategies that leverage its unique pharmacology, drawing on the latest peer-reviewed and translational evidence.

• KU-55933 (ATM Kinase Inhibitor): Precision Control of Cell C

  2026-08-04

  Explore how KU-55933, a potent ATM kinase inhibitor, enables precise modulation of cell cycle arrest and DNA damage response in cancer research. This article uniquely connects mechanistic ATM inhibition to mitochondrial metabolism, offering actionable insights for advanced experimental design.

• Translational Leverage of Zolmitriptan in Migraine and Beyon

  2026-08-04

  This thought-leadership article explores Zolmitriptan's mechanistic action as a 5-HT1B receptor agonist and its strategic value in translational migraine and cluster headache research. Blending protocol guidance, competitive context, and recent insights into lysosomal biology, it delivers actionable strategies for researchers aiming to model, validate, and innovate within serotonin receptor pharmacology.

• Pentoxifylline Modulates T Cell Responses in Leishmania and

  2026-08-03

  This study demonstrates that pentoxifylline, a non-specific phosphodiesterase inhibitor, downregulates pro-inflammatory T cell responses both in vitro and in vivo in Leishmania and HTLV-I infections. The findings clarify pentoxifylline’s mechanism as an immunomodulatory agent and support its application in experimental and clinical models of immune-driven infectious pathology.

• Bile Acid Retention Impairs Antigen Presentation in MASH-HCC

  2026-08-03

  This study uncovers a mechanistic link between intracellular bile acid retention and impaired tumor antigen presentation in metabolic dysfunction-associated steatohepatitis hepatocellular carcinoma (MASH-HCC). By elucidating the GPR120–bile acid–NLRC5 axis, the research provides new rationale for targeting bile acid metabolism to improve immunotherapy outcomes in this resistant cancer subtype.

• Intracellular Aminopeptidase Inhibition in Myeloma Cells: Me

  2026-08-02

  This study demonstrates that bestatin and actinonin inhibit myeloma cell proliferation primarily via intracellular mechanisms, challenging the long-held assumption of cell surface aminopeptidase inhibition as the main antiproliferative pathway. Modulation of cellular drug export with agents like verapamil further enhances the efficacy of these inhibitors, providing new avenues for overcoming multidrug resistance in myeloma research.

• Rottlerin as a PKC Inhibitor: Applied Workflows and Troubles

  2026-08-01

  Rottlerin stands out as a selective PKC inhibitor, enabling precise control of cell signaling, apoptosis, and barrier function in advanced experimental workflows. This article unpacks real-world protocols, troubleshooting tactics, and the latest cross-domain research leveraging Rottlerin, with a focus on maximizing reproducibility in both cancer biology and host-pathogen studies.

• Metformin Hydrochloride: Immunometabolic Modulation in Resea

  2026-07-31

  Explore how Metformin Hydrochloride (Metformin HCl) enables advanced immunometabolic research by selectively regulating metabolic pathways in immune cells. This in-depth analysis reveals unique assay design strategies and mechanistic insights distinct from fibrosis and ossification studies.

• Metformin HCl Suppresses Tendon Ossification via Nr4a1/Wnt P

  2026-07-31

  The referenced study demonstrates that Metformin Hydrochloride (Metformin HCl) effectively inhibits heterotopic ossification (HO) in mouse Achilles tendon by downregulating the Nr4a1/Wnt/β-catenin signaling axis. These findings highlight an unexpected role for metformin as a regulator of pathological bone formation in soft tissues and suggest new avenues for non-surgical HO intervention.

• HyperScript III RT SuperMix: Precision cDNA Synthesis for qP

  2026-07-30

  HyperScript III RT SuperMix streamlines accurate, high-yield cDNA synthesis from challenging RNA samples—including low-concentration and high-GC content RNA—enabling robust gene expression analysis by qPCR. Its integrated gDNA wiper ensures ultra-clean results, critical for translational workflows targeting immune-metabolic biomarkers such as CLCA1, UGT2A3, and ZG16 in colorectal cancer.

• Standardized Whole-Blood Stimulation to Probe Immunometaboli

  2026-07-30

  The reference study introduces a standardized protocol for analyzing immune responses in human whole blood under metabolic modulation. This approach enables robust assessment of how targeted metabolic interventions influence cytokine production, advancing immunometabolism research and supporting translational immune modulation strategies.

• SM-102: Mechanistic Leverage for Next-Gen mRNA Delivery

  2026-07-29

  This thought-leadership article explores the mechanistic underpinnings and translational potential of SM-102, a synthetic lipid critical to lipid nanoparticle (LNP)–mediated mRNA delivery. By integrating recent findings in bladder cancer therapy with strategic guidance for researchers, it bridges molecular insight, real-world protocols, and the evolving landscape of mRNA therapeutics.

• Streamlining PCR with 2X Taq PCR Master Mix: Protocols & Inn

  2026-07-29

  Unlock reproducible DNA amplification and direct gel loading with the 2X Taq PCR Master Mix (with dye), a robust, ready-to-use solution for genotyping, TA cloning, and infection dynamics studies. Discover protocol enhancements, troubleshooting insights, and how recent ambrosia beetle research translates to real-world assay choices.

• Recombinant Mouse IFN-γ: Precision Tools for Antigen Present

  2026-07-28

  Leverage APExBIO’s Recombinant Mouse IFN-γ (E.coli, His & Strep, Liquid) to restore and dissect antigen presentation in immunometabolic liver cancer models. This guide delivers workflow enhancements, troubleshooting strategies, and actionable insights directly connected to novel metabolic-immune mechanisms revealed by recent research.

16082 records 1/1073 page Next 12345 下5页 Last page